DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

14.85 -0.37 (-2.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACHN $14.85 -2.43%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.11
Previous Close $15.22
Daily Range $14.74 - $15.44
52-Week Range $2.45 - $16.87
Market Cap $1.5B
P/E Ratio -24.16
Dividend (Yield) $0.00 (0.0%)
Volume 2,791,244
Average Daily Volume 7,442,128
Current FY EPS -$0.67

Sector

Healthcare

Industry

Drugs

ACHILLION PHARMACEUTICALS, INC. (ACHN) Description

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/

News & Commentary Rss Feed

5 Tiny Biotech Stocks to Own in 2015

Insys Therapeutics, Achillion Pharmaceuticals, Portola Pharmaceuticals, Ophthotech, and Acceleron Pharma have intriguing pipelines that may make them stocks to own this year.

Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog

Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog

What Investors Are Watching For In Regulus Therapeutics' Next Data Release

'Mad Money' Lightning Round: I'm Worried About Martin Midstream Partners

Stay Away From Martin Midstream - Cramer's Lightning Round (1/27/15)

Achillion (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape

Achillion (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape

Deutsche Bank's Top Biotech Picks For 2015

How To Play Gilead In 2015: It's Going To Be A Bumpy Ride

I'm Expecting Some Very Positive News Flow From Gilead

Should AbbVie Inc. Or Gilead Sciences Buy These Tiny Biotech Stocks?

AbbVie Inc and Gilead Sciences may want to consider Achillion Pharmaceuticals' and Regulus Therapeutics' intriguing hepatitis C drugs.

See More ACHN News...

ACHN's Top Competitors

ACHN $14.85 (-2.43%)
Current stock: ACHN
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
BIIB $389.16 (10.17%)
Current stock: BIIB